Fidelity® Select Biotechnology Portfolio

Class No Load (FBIOX)
Scorecard
4 / 5 Stars
Lipper
5 5 2 5 4
Zacks Investment Research
3 (Hold)
Standard & Poor's
5 / 5 Stars
TheStreet.com
B (Buy)

Fund Performance

The fund's Value Line Growth Persistence rank, which awards funds that consistently outperform their broad universes, is 3 for one year, 2 for five years, and 2 for 10 years. Scores are on a 1 to 5 scale, with 1 being the best and 5 the worst.

Value Line 2014-06-11

Hypothetical Growth of $10,000

Updated 06.30.2014

Trailing Total Returns

Updated 06.30.2014

Total Return % + / - MSCI ACWI NR USD + / - S&P 1500 Health Care TR % Rank
Year-to-date 10.21 4.03 0.00 69
1-Month 7.41 5.52 5.11 20
3-Month 2.79 -2.25 -1.79 91
6-Month 10.21 4.03 0.00 69
1-Year 41.61 18.66 11.69 14
3-Year (Annualized) 35.49 25.24 13.46 1
5-Year (Annualized) 28.90 14.62 7.73 1
10-Year (Annualized) 13.85 6.38 4.25 9